Summary
Conjugated Linoleic acids (CLA) are a class of geomet ric and positional isomers of linoleic acid found in some foods such as ruminant meat and dairy products. Previ ous reports have demonstrated some beneficial effects of dietary CLA in various animal species (1, 2) such as anticarcinogenic properties in rodents (3), and delaying the onset of atherosclerosis in rabbits (4) and hamsters (5) . CLA-supplemented diets also cause massive reduc tion of body fat mass in rodents (6), pigs (7) , and proba bly in humans (8) . This CLA-induced body fat loss seems to be due to increased energy expenditure associ ated with sympathetic nerve activation, rather than decreased food intake (9) , and is isomer specific to t10, c12-CLA, but not c9, t11-CLA (10, 11) .
Since excessive accumulation of body fat usually leads to impaired glucose and lipid metabolism includ ing insulin resistance and fatty liver, CLA feeding would be expected to improve such metabolic disorders (1, 2) . However, the effects of dietary CLA on glucose and lipid metabolism are rather controversial in various animal species. ouseknecht et al. (12) reported that CLA feed ing improved insulin sensitivity and glucose tolerance in Zucker diabetic fatty fa/fa (ZDF) rats. In contrast, CLA feeding has been reported to induce hyperglyce mia, hyperinsulinemia and insulin resistance in both obese and normal mice (13, 14) and also in human subjects (8, 15) . Moreover, dietary CLA supplementa tion resulted in marked hepatomegaly associated with an excessive accumulation of intracellular triglyceride, probably due to hyperinsulinemia (11, 14) .
The objectives of the present study are to confirm the adverse metabolic effects of CLA and to examine the underlying mechanisms, with special references to the leant effect on body or WAT weights of C57BL mice, while it reduced those of KK and KKAy mice. However, the CLA-diet significantly increased liver weight, in association with excess accumulation of triglyceride, in C57BL and KK. These effects of CLA-diet were not obvi ous in morbidly obese KKAy mice, which had heavier livers and excess accumulation of triglycerides even on the control diet, The CLA-diet, compared with the con trol diet, did not produce any noticeable changes in food intake or the weights of BAT, spleen or skeletal muscle of the three strains of mice. All these results are consis tent with previous reports (10, 11, 13, 14) and collec tively indicate that dietary CLA supplementation reduces body fat and induces fatty liver to varying degrees between obese/diabetic and normal mice. CLA-induced hyperglycemia, hyperinsulineria and insulin resistance The plasma glucose and insulin in KK and KKAy mice were, as expected, higher than those in normal C57BL mice. As shown in Fig. 1 , dietary CLA supple mentation increased plasma glucose and insulin levels and the HOMA-R value, calculated from the plasma glucose and insulin levels as an index of insulin resis tance, was significantly increased in all strains of mice fed on the CLA-diet. Further, insulin resistance induced by CLA feeding, was confirmed by the insulin tolerance test (Fig. 2) . Although there was no significant differ ence in the blood glucose curves between the control and CLA-fed mice, hypoglycemic effects of insulin were less marked in KK and KKAy mice fed on the CLA diet. These results indicate that dietary CLA supplementa tion deteriorates insulin resistance, especially in obese/ diabetic mice. 
DISCUSSION
In most previous studies on the effects of dietary CLA supplementation in various animal species and also in humans, CLA has been used in the form of free fatty acids, and not the triglyceride-bound form occurring in ordinary foods such as dairy products (1) . In the present study, we prepared a diet supplemented with CLA oil at 0.15% c9, tll-CLA and 0.15% t10, c12-CLA (w/w), about 80% of which was triglyceride-bound CLA. Four-week feeding of this diet produced essentially the same changes of reduced body fat content, fatty liver, and insulin resistance as reported previously using diets supplemented with free CLA (11, 13, 14) . It is, thus, likely that the effects of the present diet are attributed to free CLA released by digestion of the tri glyceride form (22) .
It is well known that obese animals, including KK and KKAy mice used in this study, show insulin resis tance (23) , which is usually ameliorated by reduction of body fat. CLA-feeding would thus be expected to improve obesity-associated insulin resistance (1, 2), but this was not the case in the present study, Instead, the CLA-supplemented diet caused significant reduction of adipose tissue mass, especially in obese KK and KKAy mice, but paradoxically deteriorated insulin resistance. Of interest, insulin resistance is also known to be inti mately associated with lipodystrophy (24) . In fact, pro longed feeding of CLA diet of C57BL mice resulted in apoptosis of adipocytes and finally a state resembling lipoatrophic diabetes with marked reduction of adipose tissue, hepatomegaly, and severe insulin resistance (14) . Further, the CLA-induced lipoatrophic insulin resistance, like other models of lipoatrophic diabetes, was reversed by leptin treatment, suggesting that leptin depletion is the critical factor for the development of insulin resistance (17) . In the present study, however, the CLA-induced reduction of body fat was rather mod est, and the mice still had considerable adipose tissue, particularly KK and KKAy mice, unlike the state of lipo dystrophy. Moreover, the plasma leptin remained at rather higher levels even after CLA-feeding, although its mNA expression in adipose tissue was markedly decreased. Collectively, it is difficult to consider leptin as the sole factor for the CLA-induced insulin resistance observed in the present study. In summary, CLA-feeding reduces body fat mass in obese/diabetic mice, but further deteriorates insulin resistance. The CLA-induced insulin resistance may be due to decreased adipose production of adiponectin and possibly of leptin, adipocytokines known to be critical in amelioration of insulin resistance in both obese and lipodystrophic mice. This is a contrast with the effects of food restriction on obese animals, which reduces body fat, increases adiponectin production, and ameliorates insulin resistance.
